---
schema_version: "secwatch.filing_event.v1"
accession: "0001517022-24-000035"
form_type: "8-K"
ticker: "AKBA"
cik: "0001517022"
company_name: "Akebia Therapeutics, Inc."
filed_at: "2024-04-23T23:59:59+00:00"
generated_at: "2026-06-03T11:51:30.553341+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Akebia draws $8.0M Tranche B from Kreos loan facility; $10.0M Tranche C still available

## Summary
- Akebia drew $8.0M Tranche B loan on April 17, 2024, netting $7.5M after debt issuance costs and fees.
- Remaining borrowing capacity under Tranche C is $10.0M, available through December 31, 2024.
- Total facility remains $55M; initial $37M tranche was funded on January 29, 2024.

## SEC filing metadata
- accession: 0001517022-24-000035
- form_type: 8-K
- ticker: AKBA
- cik: 0001517022
- company_name: Akebia Therapeutics, Inc.
- filed_at: 2024-04-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/0001517022-24-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/akba-20242304xkreosdrawdown.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001517022-24-000035
- JSON: https://secwatch.observer/filing/0001517022-24-000035.json
- Plain text: https://secwatch.observer/filing/0001517022-24-000035.txt

## Key facts
- Debt Financings
  Akebia Therapeutics, Inc. incurred term loan of $8.0 million with Kreos Capital VII (UK) Limited, which are funds and accounts managed by BlackRock Inc..
  - Instrument: term loan
  - Principal: $8.0 million
  - Counterparty: Kreos Capital VII (UK) Limited, which are funds and accounts managed by BlackRock Inc.
  - Event: incurrence
  source text: tranche of $37.0 million, which was funded on the Closing Date. In addition to the initial tranche, the Term Loan Facility included additional tranches available as follows: $8.0 million available in a single draw through December 31, 2024 (the “Tranche B Loan”), and $10.0 million available in a single draw through December 31, 2024 (the “Tranche C Loan”). On
  evidence_url: https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/0001517022-24-000035-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.